SCARTOZZI, MARIO
 Distribuzione geografica
Continente #
EU - Europa 7.393
NA - Nord America 4.386
AS - Asia 1.344
AF - Africa 173
SA - Sud America 71
OC - Oceania 42
Totale 13.409
Nazione #
IT - Italia 6.533
US - Stati Uniti d'America 4.284
CN - Cina 622
DE - Germania 198
IN - India 155
VN - Vietnam 93
GB - Regno Unito 92
JP - Giappone 82
CA - Canada 78
BE - Belgio 73
FR - Francia 69
HK - Hong Kong 55
NL - Olanda 55
EG - Egitto 54
ZA - Sudafrica 53
ID - Indonesia 50
FI - Finlandia 49
KR - Corea 42
TW - Taiwan 41
IE - Irlanda 36
AU - Australia 34
TR - Turchia 33
RU - Federazione Russa 30
UA - Ucraina 30
AE - Emirati Arabi Uniti 29
SE - Svezia 27
PL - Polonia 26
PT - Portogallo 25
RO - Romania 25
BR - Brasile 24
PH - Filippine 22
TH - Thailandia 22
ES - Italia 21
MX - Messico 20
CZ - Repubblica Ceca 19
SG - Singapore 19
AT - Austria 18
GR - Grecia 17
IQ - Iraq 17
PE - Perù 16
CL - Cile 15
MA - Marocco 14
CH - Svizzera 13
SO - Somalia 13
IR - Iran 11
PK - Pakistan 10
CO - Colombia 9
MK - Macedonia 9
NZ - Nuova Zelanda 8
MY - Malesia 7
BD - Bangladesh 6
IL - Israele 6
NG - Nigeria 6
UG - Uganda 6
DZ - Algeria 5
BG - Bulgaria 4
EE - Estonia 4
AR - Argentina 3
CM - Camerun 3
DK - Danimarca 3
LT - Lituania 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TZ - Tanzania 3
AZ - Azerbaigian 2
GH - Ghana 2
GT - Guatemala 2
KE - Kenya 2
KH - Cambogia 2
LU - Lussemburgo 2
MM - Myanmar 2
MN - Mongolia 2
MT - Malta 2
QA - Qatar 2
SA - Arabia Saudita 2
TG - Togo 2
AL - Albania 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CI - Costa d'Avorio 1
EC - Ecuador 1
ET - Etiopia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
LY - Libia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
UY - Uruguay 1
Totale 13.407
Città #
Cagliari 5.850
Fairfield 537
Santa Cruz 364
Ashburn 335
Buffalo 284
Woodbridge 282
Houston 275
Seattle 267
Cambridge 162
Wilmington 130
Ann Arbor 101
Shanghai 97
Dong Ket 82
Beijing 81
Rome 80
Milan 71
Chicago 67
Brussels 65
Mountain View 55
Helsinki 45
Boardman 44
Las Vegas 44
Mumbai 43
Muizenberg 41
Guangzhou 39
Phoenix 39
Los Angeles 38
Changsha 35
Dublin 34
San Diego 31
New York 30
University Park 30
Clearwater 28
Ottawa 28
Tokyo 27
Cairo 23
Johnson City 23
Shenyang 23
Wuhan 22
Paris 21
Toronto 21
Nanjing 20
Central 18
Hangzhou 18
Naples 18
San Jose 18
Arezzo 17
Dallas 17
Redmond 17
Istanbul 16
Amsterdam 15
San Francisco 15
Atlanta 14
Bengaluru 14
Lima 14
Council Bluffs 13
Harbin 13
Mogadishu 13
Munich 13
Saint Petersburg 13
Chengdu 12
Henderson 12
Mexico City 12
Cedar Knolls 11
Jakarta 11
London 11
Bucharest 10
Changchun 10
Melbourne 10
New Delhi 10
Provo 10
Riva 10
Sydney 10
Bangkok 9
Shenzhen 9
Turin 9
Auburn 8
Chennai 8
Delhi 8
Easton 8
Florence 8
Hebei 8
Herndon 8
Hyderabad 8
Lit 8
Seoul 8
Silverton 8
Singapore 8
Taipei 8
Xian 8
Baotou 7
Bari 7
Chongqing 7
Gdynia 7
Guiyang 7
Hefei 7
Hong Kong 7
Milpitas 7
Nanchang 7
Osaka 7
Totale 10.538
Nome #
New therapeutic targets in pancreatic cancer, file e2f56ed8-ef81-3eaf-e053-3a05fe0a5d97 1.028
Immunotherapy associated pulmonary toxicity: Biology behind clinical and radiological features, file e2f56ed8-0bdb-3eaf-e053-3a05fe0a5d97 733
Clustered protocadherins methylation alterations in cancer, file e2f56ed8-c7b7-3eaf-e053-3a05fe0a5d97 682
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis, file e2f56ed6-8569-3eaf-e053-3a05fe0a5d97 532
ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib, file e2f56ed8-7dab-3eaf-e053-3a05fe0a5d97 503
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients, file e2f56ed5-2bb2-3eaf-e053-3a05fe0a5d97 425
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression, file e2f56ed9-9d7e-3eaf-e053-3a05fe0a5d97 417
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials, file e2f56ed8-b6c4-3eaf-e053-3a05fe0a5d97 396
Molecular classifications of gastric cancers: Novel insights and possible future applications, file e2f56ed7-2196-3eaf-e053-3a05fe0a5d97 393
null, file e2f56ed5-2859-3eaf-e053-3a05fe0a5d97 376
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer, file e2f56ed8-9a5b-3eaf-e053-3a05fe0a5d97 364
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: Training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier), file e2f56ed8-b6bb-3eaf-e053-3a05fe0a5d97 362
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study, file e2f56ed5-28ce-3eaf-e053-3a05fe0a5d97 350
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma, file e2f56ed5-285e-3eaf-e053-3a05fe0a5d97 326
Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced hcc patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group, file e2f56ed5-28d0-3eaf-e053-3a05fe0a5d97 317
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study, file e2f56ed6-8533-3eaf-e053-3a05fe0a5d97 317
Lactate dehydrogenase in hepatocellular carcinoma: something old, something new, file e2f56ed5-2c11-3eaf-e053-3a05fe0a5d97 297
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment, file 8ebc3cb7-4c88-4c30-befb-60bceaf06aed 274
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab, file e2f56ed4-40e6-3eaf-e053-3a05fe0a5d97 253
Immunotherapeutic approaches for hepatocellular carcinoma, file e2f56ed6-8b44-3eaf-e053-3a05fe0a5d97 233
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management, file e2f56ed4-f9f3-3eaf-e053-3a05fe0a5d97 213
Gold nanoparticles: A new golden Era in oncology?, file e2f56ed9-a939-3eaf-e053-3a05fe0a5d97 201
Molecular-biology-driven treatment for metastatic colorectal cancer, file e2f56ed9-4e0d-3eaf-e053-3a05fe0a5d97 182
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma, file e2f56ed5-28c7-3eaf-e053-3a05fe0a5d97 171
Prognostic value for incidental antihypertensive therapy with β-blockers in metastatic colorectal cancer, file e2f56ed4-429f-3eaf-e053-3a05fe0a5d97 157
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management, file e2f56ed4-4e6d-3eaf-e053-3a05fe0a5d97 155
Rare histotypes of epithelial biliary tract tumors: A literature review, file 7bd3d417-d8d1-4143-a033-e9258488eb70 154
BRAF-mutant colorectal cancer, a different breed evolving, file e2f56ed8-5249-3eaf-e053-3a05fe0a5d97 144
Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients, file e2f56ed4-4107-3eaf-e053-3a05fe0a5d97 137
The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment, file e2f56ed4-4199-3eaf-e053-3a05fe0a5d97 133
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib, file e2f56ed4-42aa-3eaf-e053-3a05fe0a5d97 127
The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management, file e2f56ed4-410f-3eaf-e053-3a05fe0a5d97 125
Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach, file e2f56ed4-4a50-3eaf-e053-3a05fe0a5d97 124
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab, file e2f56ed4-48f6-3eaf-e053-3a05fe0a5d97 123
Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients, file e2f56ed4-42af-3eaf-e053-3a05fe0a5d97 120
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib, file e2f56ed6-21ff-3eaf-e053-3a05fe0a5d97 120
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC), file e2f56ed6-830f-3eaf-e053-3a05fe0a5d97 115
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis, file e2f56ed5-3093-3eaf-e053-3a05fe0a5d97 112
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer, file e2f56ed8-10c4-3eaf-e053-3a05fe0a5d97 110
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology, file e2f56ed6-ba5a-3eaf-e053-3a05fe0a5d97 108
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapy, file e2f56ed9-ac71-3eaf-e053-3a05fe0a5d97 107
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib, file e2f56ed9-b6f8-3eaf-e053-3a05fe0a5d97 105
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?, file a634f0fb-0fbc-40ea-874e-ee41d1bd267b 103
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression, file 8126a541-a33e-4b36-947c-ec40fe88ca5c 98
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab, file e2f56eda-62d3-3eaf-e053-3a05fe0a5d97 97
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis, file ecb7a96a-1b3f-468d-a246-459af97f201e 97
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?, file e2f56ed9-4bd8-3eaf-e053-3a05fe0a5d97 95
Health related quality of life in patients with onco-hematological diseases, file e2f56ed9-6b04-3eaf-e053-3a05fe0a5d97 87
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study, file e2f56eda-924a-3eaf-e053-3a05fe0a5d97 76
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the “CARACAS” study, file 0a789e29-56d9-4880-bfe9-fd6082f69d39 69
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue, file e2f56eda-719d-3eaf-e053-3a05fe0a5d97 58
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients, file e2f56eda-bd0b-3eaf-e053-3a05fe0a5d97 55
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer, file cf82eb11-44e6-4087-be44-6acc7659440e 49
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples, file e2f56eda-4342-3eaf-e053-3a05fe0a5d97 45
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice, file 3db65eca-ca66-4c7b-8596-7975915bd94a 44
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression?, file 7ff92b55-0103-42d3-8d15-6ec203def5ec 43
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, file e2f56ed9-5b18-3eaf-e053-3a05fe0a5d97 41
Immune Checkpoint Inhibitors in the Treatment of HCC, file e2f56eda-9def-3eaf-e053-3a05fe0a5d97 40
Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158), file e2f56ed9-eb00-3eaf-e053-3a05fe0a5d97 33
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib, file edfe971a-b125-4e72-9c46-4e1db1eea374 28
Laparoscopic management of isolated nodal recurrence in gynecological malignancies is safe and feasible even for large metastatic nodes up to 8 cm: A prospective case series, file 2b2746e2-8824-4584-afba-1715a44e0483 27
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review, file 05e96b0e-8a56-466c-b839-5e82eea376b3 25
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment, file 4480f1a7-7551-4012-8578-67fdfd7d60d2 24
Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy, file b48f671b-9456-47da-9d14-d5fb1b470ad2 24
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice, file e2f56eda-7cb4-3eaf-e053-3a05fe0a5d97 21
Exploring Outcome Priorities and Real-Life Management of Chemotherapy-Induced Peripheral Neurotoxicity: A Survey of the Italian Association for the Study of Pain members, file f66d2587-4d50-4a9d-be10-febcd8b5bf24 21
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis, file 55532d45-5c88-4426-9c9a-ebdfa8f5db0c 20
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers, file e2f56eda-5b87-3eaf-e053-3a05fe0a5d97 20
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma, file e2f56eda-5c59-3eaf-e053-3a05fe0a5d97 19
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors, file 9dd2e0c7-2148-4e4b-b971-b3f8b5a092b8 18
The Reliability and Test-Retest Stability of the Treatment Perception Questionnaire (TPQ) in the Oncology Field: A Pilot Study, file e2f56eda-ac25-3eaf-e053-3a05fe0a5d97 18
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib, file e2f56ed4-4ea8-3eaf-e053-3a05fe0a5d97 17
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report, file 4f2d4ec2-644b-4f29-bbf0-5c70dc923036 14
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world, file e2f56eda-d69d-3eaf-e053-3a05fe0a5d97 14
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not?, file 216bdc66-524c-4ce5-afd1-8c8058d391fe 13
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study, file e2f56ed9-bcc1-3eaf-e053-3a05fe0a5d97 13
The Quality of Life of People with Solid Cancer is Less Worse than Other Diseases with better Prognosis, Except in the Presence of Depression, file e2f56eda-4437-3eaf-e053-3a05fe0a5d97 13
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study, file e2f56eda-7530-3eaf-e053-3a05fe0a5d97 13
Infections in lung cancer patients undergoing immunotherapy and targeted therapy: an overview on the current scenario, file 22bc02b0-b8fe-458b-87df-6f8de4a0c7ea 12
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab, file 4f6f63bc-9843-4c9a-b908-40a76d3380d1 12
The Innate Immune Microenvironment in Metastatic Breast Cancer, file c1e48fbe-7c7e-4d0d-92ea-01ae8555b05b 12
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment, file e2f56eda-5bf0-3eaf-e053-3a05fe0a5d97 12
Adherence to treatment in patients with solid and hematological cancers. Could spiritual and psychological support facilitate optimal adherence?, file 845cd91e-29bc-4e13-8e22-884d467d2844 11
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study, file e2f56ed8-3f6e-3eaf-e053-3a05fe0a5d97 11
Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib, file cb652948-468c-4b23-b693-8eb51f809b06 10
null, file 22ea06ba-10a2-4145-bfd5-c3979ea35895 9
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients, file bb161a49-a058-4e6a-acfd-638cc3948a84 9
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy, file e2f56ed5-cd3c-3eaf-e053-3a05fe0a5d97 9
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey, file e2f56eda-7cac-3eaf-e053-3a05fe0a5d97 9
Cancer cachexia and chronic inflammation: an unbreakable bond, file 589e8939-526f-4c4a-a859-4b791ec9f308 8
Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?, file e2f56ed5-285b-3eaf-e053-3a05fe0a5d97 8
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world, file e2f56ed6-836b-3eaf-e053-3a05fe0a5d97 8
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6, file e2f56ed7-cd11-3eaf-e053-3a05fe0a5d97 8
Low adherence to therapy and co-morbid depressive episodes are independent determinants of early death in people with cancer, file 1b308f47-84ea-4e3a-b59a-5e6f789f085e 7
Fused deep learning paradigm for the prediction of o6-methylguanine-DNA methyltransferase genotype in glioblastoma patients: A neuro-oncological investigation, file 63ed1bc8-f7a4-4c26-bf46-e79c152d8e68 7
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research, file e2f56ed5-6683-3eaf-e053-3a05fe0a5d97 7
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma, file e2f56ed6-83c1-3eaf-e053-3a05fe0a5d97 7
Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy, file e2f56ed8-5fc3-3eaf-e053-3a05fe0a5d97 7
null, file e2f56eda-5bee-3eaf-e053-3a05fe0a5d97 7
The ideal reporting of RAS testing in colorectal adenocarcinoma: a pathologists' perspective, file fb06d9dd-04a3-4a9b-9534-2d30f530df37 7
Totale 13.310
Categoria #
all - tutte 29.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019457 0 0 0 0 0 0 0 0 0 113 178 166
2019/20203.045 186 96 80 131 845 863 358 122 130 66 65 103
2020/20214.152 115 236 112 1.133 957 288 303 175 136 170 245 282
2021/20221.813 192 125 97 128 165 83 97 144 64 74 435 209
2022/20231.642 109 62 322 208 83 79 103 89 165 136 156 130
2023/20241.625 118 142 172 141 191 178 166 165 222 130 0 0
Totale 13.669